ISTH 2022 Congress
COVID and Coagulation » COVID and Coagulation, Basic Science
Theme Navigation
- ISTH 2022 Congress
- COVID and Coagulation
- COVID and Coagulation, Basic Science
- COVID and Coagulation
-
Abstract Number: VPB0607
A Comparison of eNOS-based Platelet Subpopulation Ratios and Platelet VEGF Content within COVID-19
-
Abstract Number: PB0604
Abridging Molecular System Network of COVID-19 and Thrombosis
-
Abstract Number: PB0600
ADAMTS13 activity and non-parallel vWF Ristocetin CoFactor activity are associated with severity of COVID-19 infection
-
Abstract Number: VPB0611
Alteration of circulating ACE2 regulating microRNAs profiles in patients with COVID-19
-
Abstract Number: PB0592
Altered Fibrin Network Structure and Fibrinolysis in Intensive Care Unit Patients with COVID-19, Not Entirely Explaining the Increased Risk of Thrombosis
-
Abstract Number: VPB0612
Angiostatin and Plasminogen Levels as Risk Factors for Mortality in Hospitalized Covid-19 Patients
-
Abstract Number: PB0596
Anti-SARS-CoV-2 vaccines do not induce a hypercoagulable state in healthy individuals
-
Abstract Number: PB0599
Association of heme/hemopexin/heme-oxygenase 1 pathway with clinical and laboratory markers of severity in Covid-19
-
Abstract Number: OC 05.4
Biphasic thrombus formation and resolution during a coronavirus infection in the liver
-
Abstract Number: OC 57.3
Cell-based high throughput screening to identify FDA/EMA approved drugs that inhibit the endothelial pro-thrombotic switch during severe COVID19 infection
-
Abstract Number: VPB0609
Characterization of TF positive small extracellular vesicles in SARS-CoV-2 infection
-
Abstract Number: VPB0608
Circulating levels of podoplanin and CLEC-2 in COVID-19: an exploratory study
-
Abstract Number: PB0591
Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98%
-
Abstract Number: VPB0614
Coagulopathy associated with COVID-19 (CAC)
-
Abstract Number: PB0605
COVID-19 disease is associated with a hypofibrinolytic state driven by elevated plasminogen activator inhibitor-1 and its cofactor vitronectin
-
Abstract Number: PB0598
Demonstration of Prothrombotic Status in patients with COVID-19 using Thromboelastography and a Novel T-TAS assay
-
Abstract Number: OC 33.4
Detection of platelet-activating antibodies associated with VITT by flow cytometry: an italian experience
-
Abstract Number: PB0601
Differential expression of platelet microRNAs in hospitalized patients with severe COVID-19